Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Atypral 10mg


Contraindicated
Risk of congenital anomalies

Not recommended
Atypral 10mg :
Type Medicine Authorised
Originator Abilify 10mg*
Agent Mediterranean Pharmaceutical Company
Distributor Mediterranean Pharmaceutical Company
Laboratory Pharminicio
Responsible Party Pharminicio SL
Origin Spain
Manufacturer Pharminicio SL
Manufacturing Type G
Origin Spain
ATC N05AX12

Your comment will appear shortly after approval

Atypral 10mg :

Revision Date : 24/04/2015


Effect Frequency
Abdominal discomfort Not known
Abdominal pain upper Common
Agitation Not known
Akathisia Very Common
Alopecia Not known
ALT increased Not known
Anaphylactic reactions Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anxiety Common
AST increased Not known
Blood alkaline phosphatase increased Not known
Blood creatine phosphokinase increased Not known
Blood glucose fluctuation Not known
Blood glucose increased Not known
Blood prolactin decreased Not known
Bradycardia Not known
Cardiac arrest Not known
Cerebrovascular accident Not known
Chest pain Not known
Completed suicide Not known
Constipation Common
Death Not known
Decreased appetite Not known
Deep vein thrombosis Not known
Depression Uncommon
Diabetes mellitus Not known
Diabetic hyperosmolar coma Not known
Diabetic ketoacidosis Not known
Diarrhoea (Diarrhea) Not known
Diplopia Uncommon
Dizziness Common
Dry mouth (Xerostomia) Common
Dyskinesia Common
Dyspepsia Common
Dysphagia Not known
Dystonia Not known
ECG QT prolonged Not known
Embolism venous Not known
Extrapyramidal disorder Very Common
Face oedema Not known
Fatigue Very Common
Gamma-GT increased Not known
Generalized tonic-clonic seizure Not known
Glycosylated haemoglobin increased Not known
Headache Common
Heart rate increased Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Not known
Hepatitis Not known
Hyperglycaemia Not known
Hyperhidrosis Not known
Hypersensitivity Not known
Hypersexuality Uncommon
Hypertension Not known
Hyponatraemia (Hyponatremia) Not known
Hypothermia Not known
Increased appetite Common
Insomnia Common
Jaundice Not known
Laryngospasm Not known
Leucopenia (Leukopenia) Not known
Muscle twitching (Muscle twitch) Common
Musculoskeletal stiffness Not known
Myalgia Not known
Nausea Common
Nervousness Not known
Neuroleptic malignant syndrome Not known
Neutropenia Not known
Oedema peripheral Not known
Oropharyngeal spasm Not known
Orthostatic hypotension Common
Pancreatitis Not known
Pathological gambling Not known
Photosensitivity reaction Not known
Pneumonia aspiration Not known
Priapism Not known
Pruritus Not known
Pulmonary embolism Not known
Pyrexia Not known
Restlessness Common
Rhabdomyolysis Not known
Salivary hypersecretion Common
Sedation Very Common
Seizures Not known
Serotonin syndrome Not known
Skin rash Not known
Somnolence Very Common
Speech disorder Not known
Sudden death Not known
Suicidal ideation Not known
Suicide attempt Not known
Swollen tongue Not known
Syncope Not known
Tachycardia Uncommon
Tardive dyskinesia Not known
Temperature regulation disorder Not known
Thrombocytopenia (Thrombopenia) Not known
Tongue oedema Not known
Torsade de pointes Not known
Tremor Common
Urinary incontinence Not known
Urinary retention Not known
Urticaria Not known
Ventricular arrhythmia Not known
Vision blurred Common
Vomiting Common
Weight decreased (Weight loss) Not known
Weight increased (weight gain) Common
Withdrawal syndrome neonatal Not known

Different Units By MoH Code

Revision Date : no date

Atypral 10mg  MoH 11639 :
Form Tablet
Package Size Box of 28
Strength 10mg
Public Price 712236.52 L.L.
Stratum A1
NSSF ✘
Quarantine ✘
Reg. Number 38416/1
Submission date 2024
Registration Year 13/06/2024


NB : Reregistration in 2024 with different manufacturer & MAH

Price Comparison

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 28
● Pack size unit used: 28
● Cost/Unit: 25437.02 LBP ( 25,437.02 LBP )
● Pricing Date: 12/12/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info